Back to Search
Estrostep Fe 21
by Allergan Pharmaceuticals International LtdContraceptionCOCP
DiscontinuedReference Drug

Estrogen

Ethinyl Estradiol

0.02Mg,0.03Mg,0.035Mg

Progestin

Norethindrone Acetate

1Mg,1Mg,1Mg

Regimen Protocol

Triphasic Pill 21 day

Androgenicity

Moderate

Approval Date

10/9/1996

Additives
ferrous fumarate
Inactive Ingredients
lactosecalcium stearatemicrocrystalline cellulosestarch

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Novast Laboratories Ltd

Chabelina Fe

Xiromed Llc

Norethindrone Acetate And Ethinyl Estradiol

Mayne Pharma Inc.

Tilia Fe

Barr Laboratories Inc

Tri-Legest Fe

Have clinical questions about Estrostep Fe 21?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy